Malignant external otitis – evaluation of prognostic factors

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025149

Enrollment

200

Registered

2021-04-23

Start date

2021-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

H60.2

Interventions

Group 1: The database of the University Medical Center Freiburg is searched for patients with malignant otitis externa. For all patients with the diagnosis of malignant otitis externa, additional data

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Treatment for external otitis maligna at Freiburg University Hospital between 2000 and 2020. The presence of otitis externa maligna is defined according to the criteria of Cohen and Friedman (1987).

Exclusion criteria

Exclusion criteria: Age under 18 years

Design outcomes

Primary

Measure	Time frame
Identification of prognostic factors for improvement of the leading symptom in patients* with otitis externa maligna.	—

Secondary

Measure	Time frame
(a) Identification of prognostic factors for the duration of antibiotic infusion therapy. (b) Influence of different therapy options (antibiotic therapy, surgery, HbO therapy) and therapy combinations on the improvement of the leading symptom in patients with otitis externa maligna.	—

Countries

Germany

Contacts

Public ContactIva Speck

HNO-Uniklinik Freiburg

iva.speck@uniklinik-freiburg.de0761/270-41964

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026